(Q41151451)

27 September 2017

title

Heparin and dextran sulfate antagonize PGI2 inhibition of platelet aggregation (English)

1 reference

https://api.crossref.org/works/10.1016/0049-3848(79)90206-8

19 April 2023

1 reference

1 reference

Prostaglandin antagonists

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A392805

19 April 2023

author name string

A. Eldor

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A392805

19 April 2023

B. B. Weksler

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A392805

19 April 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=392805

19 April 2023

publication date

1 January 1979

1 reference

full work available at URL

27 September 2017

https://api.elsevier.com/content/article/PII:0049384879902068?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0049-3848(79)90206-8

https://api.elsevier.com/content/article/PII:0049384879902068?httpAccept=text/plain

19 April 2023

1 reference

https://api.crossref.org/works/10.1016/0049-3848(79)90206-8

19 April 2023

1 reference

27 September 2017

volume

16

1 reference

27 September 2017

issue

5-6

1 reference

27 September 2017

page(s)

617-628

1 reference

Human arterial and venous tissues generate prostacyclin (prostaglandin x), a potent inhibitor of platelet aggregation

27 September 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0049-3848(79)90206-8

Cyclic AMP and platelet function

19 April 2023

3

1 reference

https://api.crossref.org/works/10.1016/0049-3848(79)90206-8

Prostacyclin increases cyclic AMP levels and adenylate cyclase activity in platelets

19 April 2023

5

1 reference

https://api.crossref.org/works/10.1016/0049-3848(79)90206-8

Effects of prostacyclin (PGX) on cyclic AMP concentrations in human platelets

19 April 2023

6

1 reference

https://api.crossref.org/works/10.1016/0049-3848(79)90206-8

Heparin: A potent inhibitor of ovarian luteinizing hormone-sensitive adenylate cyclase

19 April 2023

7

1 reference

https://api.crossref.org/works/10.1016/0049-3848(79)90206-8

Modulation of adenylate cyclase activity by sulfated glycosaminoglycans I. Inhibition by heparin of gonadotropin- stimulated ovarian adenylate cyclase

19 April 2023

8

1 reference

https://api.crossref.org/works/10.1016/0049-3848(79)90206-8

Modulation of adenylate cyclase activity by sulfated glycosaminoglycans II. Effects of mucopolysaccharides and dextran sulfate on the activity of adenylate cyclase derived from various tissues

19 April 2023

9

1 reference

https://api.crossref.org/works/10.1016/0049-3848(79)90206-8

The effects of dextran sulfate, heparin and PGE1 on adenylate cyclase activity and aggregation of human platelets

19 April 2023

11

1 reference

https://api.crossref.org/works/10.1016/0049-3848(79)90206-8

Synthesis of prostaglandin I2 (prostacyclin) by cultured human and bovine endothelial cells

19 April 2023

12

1 reference

https://api.crossref.org/works/10.1016/0049-3848(79)90206-8

On the mechanism of platelet aggregation induced by heparin, protamine and polybrene

19 April 2023

13

1 reference

https://api.crossref.org/works/10.1016/0049-3848(79)90206-8

Platelet Aggregation Following Heparin and Protamine Administration

19 April 2023

15

1 reference

https://api.crossref.org/works/10.1016/0049-3848(79)90206-8

Effect of platelet activity of inhibition of adenylate cyclase

19 April 2023

16

1 reference

https://api.crossref.org/works/10.1016/0049-3848(79)90206-8

Cyclic nucleotides in platelet function

19 April 2023

17

1 reference

https://api.crossref.org/works/10.1016/0049-3848(79)90206-8

Morphine antagonises prostaglandin E1- mediated inhibition of human platelet aggregation

19 April 2023

18

1 reference

https://api.crossref.org/works/10.1016/0049-3848(79)90206-8

The interaction of platelets with a tritium-labelled heparin

19 April 2023

19

1 reference

https://api.crossref.org/works/10.1016/0049-3848(79)90206-8

Selective Binding Site for [3H]Prostacyclin on Platelets

19 April 2023

20

1 reference

https://api.crossref.org/works/10.1016/0049-3848(79)90206-8

Heparin-induced thrombocytopenia. An unexpected response to treatment of consumption coagulopathy

19 April 2023

22

1 reference

https://api.crossref.org/works/10.1016/0049-3848(79)90206-8

Editorial: Thrombocytopenia occurring during heparin therapy

19 April 2023

23

1 reference

https://api.crossref.org/works/10.1016/0049-3848(79)90206-8

Heparin induced thrombocytopenia with thrombotic and hemorrhagic manifestations

19 April 2023

24

1 reference

https://api.crossref.org/works/10.1016/0049-3848(79)90206-8

Disseminated Intravascular Coagulation During Heparin Therapy

19 April 2023

25

1 reference

https://api.crossref.org/works/10.1016/0049-3848(79)90206-8

Binding of heparin on the surface of cultured human endothelial cells

19 April 2023

27

1 reference

https://api.crossref.org/works/10.1016/0049-3848(79)90206-8

Binding of heparin on the surface of cultured human endothelial cells

19 April 2023

28

1 reference

https://api.crossref.org/works/10.1016/0049-3848(79)90206-8

Prostacyclin can replace heparin in haemodialysis in dogs

19 April 2023

29

1 reference

https://api.crossref.org/works/10.1016/0049-3848(79)90206-8

Anti-platelet action of intravenous infusion of prostacyclin in man

19 April 2023

30

1 reference

https://api.crossref.org/works/10.1016/0049-3848(79)90206-8

Successful therapy of advanced arteriosclerosis obliterans with prostacyclin

19 April 2023

31

1 reference

https://api.crossref.org/works/10.1016/0049-3848(79)90206-8

19 April 2023

Identifiers

1 reference

27 September 2017

1 reference